Research Topics
| S C TextorSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Percutaneous revascularization for ischemic nephropathy: the past, present, and futureStephen C Textor
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Kidney Int 83:28-40. 2013....
Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whitesStephen C Textor
Mayo Clinic, Rochester, MN 55905, USA
Am J Kidney Dis 59:229-37. 2012....
Current approaches to renovascular hypertensionStephen C Textor
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Med Clin North Am 93:717-32, Table of Contents. 2009..These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease...
Blood pressure evaluation among older living kidney donorsStephen C Textor
Department of Internal Medicine, Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, Minnesota, USA
J Am Soc Nephrol 14:2159-67. 2003..Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors...
Expanding criteria for living kidney donors: what are the limits?Stephen Textor
Mayo Clinic, Rochester, MN 55905, USA
Transplant Rev (Orlando) 22:187-91. 2008..Studies to closely track the impact of donor nephrectomy in the current era with changing population demographics and expectations are essential...
The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosisStephen C Textor
Division of Nephrology and Hypertension, Departments of Physiology and Pathology, Center for Magnetic Imaging Research and Department of Radiology, Mayo Clinic, W19, Rochester, MN 55905, USA
J Am Soc Nephrol 19:780-8. 2008..These results suggest that BOLD MR coupled with a method to suppress tubular oxygen consumption can be used to evaluate regional tissue oxygenation in the human kidney affected by vascular occlusive disease...
Atherosclerotic renal artery stenosis: overtreated but underrated?Stephen C Textor
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
J Am Soc Nephrol 19:656-9. 2008..Most important, nephrologists await development of tools to predict reliably when renal parenchymal injury is beyond recovery and/or when revascularization can produce meaningful salvage of kidney function...
Blood pressure and renal function after kidney donation from hypertensive living donorsStephen C Textor
Department of Medicine, Divisions of Nephrology and Hypertension, W9A, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Transplantation 78:276-82. 2004..This study reports outcomes of hypertensive donors 1 year after kidney donation...
Ischemic nephropathy: where are we now?Stephen C Textor
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
J Am Soc Nephrol 15:1974-82. 2004..Further research should be directed toward identification of critical disease, regulation of fibrogenesis, and the interaction with other atherosclerotic processes...
Hypertension after renal transplantationS C Textor
Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
J Hum Hypertens 18:835-6. 2004
Atherosclerotic renal artery stenosis: how big is the problem, and what happens if nothing is done?Stephen C Textor
Mayo Clinic College of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
J Hypertens Suppl 23:S5-13. 2005..Renal revascularization should be considered in viable individuals before the development of advanced renal insufficiency...
Progressive hypertension in a patient with "incidental" renal artery stenosisStephen C Textor
Division of Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Hypertension 40:595-600. 2002
Managing renal arterial disease and hypertensionStephen C Textor
Mayo Medical School, Division of Hypertension, Mayo Clinic Rochester, Minnesota 55905, USA
Curr Opin Cardiol 18:260-7. 2003..Recognizing renal artery disease and directing revascularization procedures to those with the most benefit remains a premier challenge for the clinician...
The uncertain value of renal artery interventions: where are we now?Stephen C Textor
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
JACC Cardiovasc Interv 2:175-82. 2009....
Posttransplantation hypertension related to calcineurin inhibitorsS C Textor
Department of Medicine, Division of Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 6:521-30. 2000..Attention must be paid to interactions between antihypertensive agents and calcineurin inhibitor blood levels...
Renal artery stenosis: a common, treatable cause of renal failure?S C Textor
Divisions of Hypertension and Nephrology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
Annu Rev Med 52:421-42. 2001..The decision to recommend revascularization remains a difficult balance between the risks and expense of the procedure and the undoubted benefits that accrue if renal function is successfully stabilized...
Renovascular hypertension and ischemic nephropathyStephen C Textor
Mayo Clinic, Rochester, Minnesota, USA
Am J Hypertens 23:1159-69. 2010..Until additional staging tools become available, clinicians will be forced to individualize therapy carefully to optimize the potential benefits regarding both blood pressure and renal function for such patients...
Renovascular hypertension in 2007: where are we now?Stephen C Textor
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Curr Cardiol Rep 9:453-61. 2007..The CORAL study and others seek to randomly assign subjects with high-grade renovascular lesions to optimal medical management with and without stenting...
Timing and selection for renal revascularization in an era of negative trials: what to do?Stephen C Textor
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Prog Cardiovasc Dis 52:220-8. 2009....
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approachesEfrain Reisin
Section of Nephrology and Hypertension, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
Med Clin North Am 93:733-51. 2009..Although we strongly believe in our proposal, more multicenter long-term clinical pharmacological trials are needed to evaluate the efficacy and safety of the antihypertensive approaches in the treatment of obesity hypertension...
Glomerular volume and renal histology in obese and non-obese living kidney donorsD J Rea
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55904, USA
Kidney Int 70:1636-41. 2006..08). From these data, our studies detected subtle differences in donor organs obtained from obese compared to non-obese individuals. Further studies should be carried out to quantify the long-term impact of these findings...
Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulationsS J Taler
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Hypertens 13:231-9. 2000..5%, normal 13%), usually absent early after transplantation. Our results demonstrate the ability of hemodynamic measurements to predict the symptomatic response to antihypertensive therapy in the posttransplant setting...
The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantationN Leung
Division of Nephrology and Hypertension, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA
Am J Transplant 10:558-62. 2010..Improvement in the dialysis patients was all partial. Successful KTx did not insure improvement in NSF and in fact appeared to have no significant benefit over dialysis...
Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidneyVictor H Urbieta-Caceres
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Physiol Renal Physiol 299:F135-40. 2010..These observations underscore the direct intrarenal effect of atherogenic factors on the kidneys...
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN)H M Wadei
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Am J Transplant 6:1025-32. 2006..iii) Fibrosis at the time of diagnosis predicts subsequent functional decline. Further elucidation of the natural history of PVAN and its response to individual interventions will require prospective clinical trials...
Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomyJulie K Heimbach
Mayo Clinic College of Medicine, Department of Transplant Surgery, Rochester, Minnesota, USA
Am J Transplant 5:1057-64. 2005..While early results are encouraging, we advocate careful study of obese donors and do not support their widespread use until longer follow-up is available...
Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapyS J Taler
Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Am J Hypertens 8:598-605. 1995..Both immunosuppressive regimens led to a loss of nocturnal blood pressure fall, as compared to ESLD patients or normotensive controls.(ABSTRACT TRUNCATED AT 250 WORDS)..
Renovascular hypertension and ischemic nephropathyVesna D Garovic
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Circulation 112:1362-74. 2005
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosisAlejandro R Chade
Department of Internal Medicine, Division of Hypertension, Mayo Clinic, Rochester, Minn 55905, USA
Arterioscler Thromb Vasc Biol 23:1295-301. 2003..These alterations might contribute to renal disease progression in ARVD and might account for the increased propensity for end-stage renal disease...
Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantationMary E Fidler
Department of Laboratory Medicine, Division of Anatomic Pathology, Mayo Foundation and Clinic, Rochester, MN, USA
Am J Transplant 4:101-7. 2004..Glomerular thrombi appear early in AMR and may appear prior to graft dysfunction...
Stable patients with atherosclerotic renal artery stenosis should be treated first with medical managementStephen C Textor
Division of Hypertension, Mayo Clinic, Rochester, MN, USA
Am J Kidney Dis 42:858-63. 2003
Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosisMonika L Gloviczki
Department of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Hypertension 55:961-6. 2010..1+/-2.2 versus 58.1+/-1.2; P=0.006). These data indicate that, although stenosis reduced blood flow and volume, cortical and medullary oxygenation was preserved under these conditions...
Revisiting the role of nephrectomy for advanced renovascular diseaseGarvan C Kane
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Med 114:729-35. 2003....
Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smallerSanjay Misra
Department of Radiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Alfred 6460, Rochester, MN 55905, USA
J Vasc Interv Radiol 19:833-9. 2008..To describe restenosis and clinical outcomes with drug-eluting stents (DESs) and compare them to those of bare metal stents (BMSs) in the treatment of symptomatic atherosclerotic renal artery stenosis (RAS) in the same patients...
Embolic protection devices in patients with renal artery stenosis with chronic renal insufficiency: a clinical studySanjay Misra
Department of Radiology, Mayo Clinic College of Medicine, 200 First Street Southwest, Alfred 6460, Rochester, MN 55902, USA
J Vasc Interv Radiol 19:1639-45. 2008..To present clinical outcomes with the use of embolic protection devices (EPDs) and renal artery stents in patients with chronic renal insufficiency (CRI) and renal artery stenosis (RAS)...
Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertensionSabas I Gomez
Department of Physiology and Biomedical Engineering, Rochester, MN 55905, USA
Am J Physiol Renal Physiol 297:F981-6. 2009..This approach may allow more detailed physiologic evaluation of poststenotic kidneys in renovascular hypertension than previously possible...
Mechanisms of tissue injury in renal artery stenosis: ischemia and beyondLilach O Lerman
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Prog Cardiovasc Dis 52:196-203. 2009..Identification of specific pathways producing progressive renal injury may enable development of targeted interventions to block these pathways and preserve the stenotic kidney...
Resistant hypertension: comparing hemodynamic management to specialist careSandra J Taler
Department of Medicine, Division of Hypertension and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Hypertension 39:982-8. 2002....
Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiographyCharanjit S Rihal
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 77:309-16. 2002..Therefore, screening abdominal aortography should be considered in these patients to better define their risk of cardiovascular complications...
Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donorsAndrew D Rule
Division of Nephrology and Hypertension, Mayo Clinic, 200 First St SW, Rochester, MN 55905
Mayo Clin Proc 86:282-90. 2011..To test the hypothesis that kidney function and metabolic risk factors are associated with glomerular density on renal biopsy samples from healthy adults...
The association between age and nephrosclerosis on renal biopsy among healthy adultsAndrew D Rule
Mayo Clinic, Rochester, Minnesota, USA
Ann Intern Med 152:561-7. 2010..Chronic kidney disease is common with older age and is characterized on renal biopsy by global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis...
Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive indexHani M Wadei
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
J Am Soc Nephrol 18:1607-15. 2007..Further studies are needed to determine whether restoration of normal BP pattern will confer better allograft outcome...
Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvementNelson Leung
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, MN, USA
Am J Transplant 5:1660-70. 2005..This experience supports the feasibility of sequential living donor KTx and autologous SCT for carefully selected patients with ESRD due to AL...
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantationFernando G Cosio
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Kidney Int 67:2415-21. 2005..Post-transplant diabetes (PTDM) is a common and serious complication of kidney transplantation. The implications of developing hyperglycemia of lesser severity are not well understood...
Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFRLourdes S Peña de la Vega
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Kidney Int 66:1654-61. 2004..Donor age adversely affects deceased-donor kidney transplant outcomes, but its influence on living-donor transplantation is less well characterized...
Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantationTimothy S Larson
Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 559805, USA
Transplantation 77:838-43. 2004..Although the shorter waiting time and the ability to use living-donor kidneys make PAK an increasingly attractive alternative to SPK transplantation, its effect on renal allograft function deserves further attention...
Kidney allograft fibrosis and atrophy early after living donor transplantationFernando G Cosio
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic and Foundation, Rochester, Minnesota, USA
Am J Transplant 5:1130-6. 2005..GIF frequently develops in the absence of risk factors. Lower GFR post-transplant identify patients at highest risk of GIF...
Renovascular hypertension updateStephen C Textor
Division of Nephrology and Hypertension, Department of Internal Medicine, 200 First Street, Mayo Clinic, Rochester, MN, 55905 0002, USA
Curr Hypertens Rep 8:521-7. 2006..This important trial employs distal embolic protection to prevent deterioration of renal function. Understanding the optimal role for renal revascularization depends heavily upon the successful conduct of such trials...
Hypertension in the kidney transplant recipientHani M Wadei
Department of Transplantation, Mayo Clinic College of Medicine, Jacksonville, FL, USA
Transplant Rev (Orlando) 24:105-20. 2010....
Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diureticsLizette Warner
Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA
Invest Radiol 46:41-7. 2011..Therefore, the adjunct use of diuretics that inhibit Na reabsorption selectively in PT and TAL, Az and furosemide, respectively, may help discern tubular function by using BOLD MRI to detect changes in tissue oxygenation...
Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejectionHani M Wadei
Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA
J Am Soc Hypertens 5:39-47. 2011..46, P = .01; r = 0.34, P = .03). The current study indicates that abnormal circadian BP pattern at 1 year identifies a group of kidney recipients at risk for increased kidney function loss and lower GFR 3-4 years from transplantation...
Pathophysiology of ischemic nephropathyL Lerman
Divisions of Hypertension and Nephrology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
Urol Clin North Am 28:793-803, ix. 2001..Improved understanding of these mechanisms is essential in preventing irreversible interstitial fibrosis and restoring renal perfusion...
Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular diseaseMonika L Gloviczki
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Invest Radiol 44:566-71. 2009..We sought to define the differences between regions within kidneys and to optimize selection of regions of interest for study with 1.5 and 3 Tesla systems...
Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertensionJingfei Cheng
Department of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Am J Physiol Renal Physiol 297:F1055-68. 2009..Notably, an unexpected proliferative response occurs in the stenotic kidney that undergoes atrophy...
Restenosis following percutaneous renal artery revascularizationGarvan C Kane
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nephron Clin Pract 107:c63-9. 2007..The aims of this study were to determine the risk factors for restenosis and to evaluate the blood pressure outcomes of patients who underwent repeat PTRA...
Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemiaAlejandro R Chade
Division of Nephrology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
Hypertension 46:772-9. 2005..Notably, many of these pathways may be reversible in hypercholesterolemia, and crucial targets could potentially be identified for early interventions to preserve the kidney...
Overcoming a positive crossmatch in living-donor kidney transplantationJames M Gloor
Department of Medicine, Division of Nephrology, Mayo Foundation and Clinic, 200 First St SW, Rochester, MN 55905, USA
Am J Transplant 3:1017-23. 2003..Longer follow-up will be needed, but the absence of anti-donor antibody and good early outcomes are encouraging...
Renovascular hypertension: current conceptsVesna Garovic
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
Semin Nephrol 25:261-71. 2005..Hence, management of such patients requires close attention and periodic review regarding restenosis and progression of vascular disease...
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomesGarvan C Kane
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
Nephrol Dial Transplant 23:1233-40. 2008..The aim of this study was to assess the results of gadolinium use to facilitate PTRA in patients with chronic kidney disease...
Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemiaAlejandro R Chade
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Am Soc Nephrol 17:3394-403. 2006..This study suggests novel renoprotective effects of ET-A blockers and supports further exploration of strategies that target the ET pathway in HC and atherosclerosis...
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimusT S Larson
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Am J Transplant 6:514-22. 2006..This study shows that a CNI-free regimen using sirolimus-MMF-prednisone produces similar acute rejection rates, graft survival and renal function 1-2 years after transplantation compared to tacrolimus-MMF-prednisone...
Endothelial progenitor cells homing and renal repair in experimental renovascular diseaseAlejandro R Chade
Divisions of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
Stem Cells 28:1039-47. 2010..Importantly, manipulation of homing signals may potentially allow therapeutic opportunities to increase endogenous EPC recruitment...
Decline in native renal function early after bladder-drained pancreas transplantation aloneMarek J Mazur
Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 55905, USA
Transplantation 77:844-9. 2004..These data suggest the need for strategies to prevent or minimize the decline in renal function after PTA...
Incidence and prognostic importance of acute renal failure after percutaneous coronary interventionCharanjit S Rihal
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Circulation 105:2259-64. 2002..0 mg/dL are at higher risk than nondiabetic patients, whereas all patients with a serum Cr >2.0 are at high risk for ARF. ARF was highly correlated with death during the index hospitalization and after dismissal...
Surgical management of renal fibromuscular dysplasia: challenges in the endovascular eraMichele Carmo
Division of Vascular Surgery, Mayo Clinic, Rochester, MN 55905, USA
Ann Vasc Surg 19:208-17. 2005..No patient developed acute or chronic renal failure. Surgical reconstruction for RFMD has excellent short-term patency. Failed PTRA or complex reconstructions did not adversely affect outcome...
HypertensionDavid G Warnock
Nephrology Research and Training Center, and Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35213, USA
Am J Kidney Dis 44:369-75. 2004
Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertensionDaniel G Hackam
Division of Clinical Pharmacology, University of Western Ontario, London, Ontario, Canada
Hypertension 50:998-1003. 2007
Pitfalls in imaging for renal artery stenosisStephen C Textor
Ann Intern Med 141:730-1. 2004
Renovascular hypertension: problems in evaluation and managementRobert A Kloner
Heart Institute, Good Samaritan Hospital and Section of Cardiology, University of Southern California, Los Angeles, CA, USA
Chest 121:964-8. 2002
Early referral for chronic kidney disease: good for those who need it, but who are they?Gary L Schwartz
Mayo Clin Proc 81:1420-2. 2006
Cardiovascular risk linked to chronic kidney disease--but who actually has chronic kidney disease?Andrew D Rule
Mayo Clin Proc 80:1267-9. 2005
The new hypertension guidelines from JNC 7: is the devil in the details?Stephen C Textor
Mayo Clin Proc 78:1078-81. 2003
Acute renal failure after liver transplantation: the role of dopamine and fenoldopamNelson Leung
Liver Transpl 10:993-4. 2004
Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomyHatem Amer
J Urol 180:780. 2008
